Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Penumbra Inc (PEN)

Penumbra Inc (PEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,033,778
  • Shares Outstanding, K 39,243
  • Annual Sales, $ 1,404 M
  • Annual Income, $ 177,690 K
  • EBIT $ 189 M
  • EBITDA $ 207 M
  • 60-Month Beta 0.84
  • Price/Sales 9.27
  • Price/Cash Flow 77.11
  • Price/Book 9.09

Options Overview Details

View History
  • Implied Volatility 11.74% (-3.29%)
  • Historical Volatility 8.10%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 56.95% on 10/20/25
  • IV Low 11.74% on 04/17/26
  • Expected Move (DTE 26) 6.80 (2.05%)
  • Put/Call Vol Ratio 0.89
  • Today's Volume 17
  • Volume Avg (30-Day) 105
  • Put/Call OI Ratio 0.99
  • Today's Open Interest 7,848
  • Open Int (30-Day) 7,694
  • Expected Range 325.33 to 338.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $1.11
  • Number of Estimates 5
  • High Estimate $1.14
  • Low Estimate $1.07
  • Prior Year $0.83
  • Growth Rate Est. (year over year) +33.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
326.58 +1.70%
on 03/30/26
338.98 -2.02%
on 03/19/26
-5.87 (-1.74%)
since 03/17/26
3-Month
326.58 +1.70%
on 03/30/26
362.41 -8.36%
on 01/21/26
-18.65 (-5.32%)
since 01/16/26
52-Week
221.26 +50.11%
on 11/03/25
362.41 -8.36%
on 01/21/26
+54.78 (+19.75%)
since 04/17/25

Most Recent Stories

More News
1 Mid-Cap Stock on Our Buy List and 2 We Ignore

1 Mid-Cap Stock on Our Buy List and 2 We Ignore

RBA : 104.17 (+0.85%)
PEN : 332.13 (+0.20%)
FTV : 60.52 (+1.46%)
Are OMEX, PEN, SNCY, CWAN Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

OMEX : 1.0600 (-4.50%)
SNCY : 18.33 (+6.69%)
PEN : 332.13 (+0.20%)
CWAN : 24.11 (unch)
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Penumbra , Inc....

BSX : 64.23 (+1.28%)
PEN : 332.13 (+0.20%)
Penumbra (NYSE:PEN): Strongest Q4 Results from the Medical Devices & Supplies - Cardiology, Neurology, Vascular Group

Penumbra (NYSE:PEN): Strongest Q4 Results from the Medical Devices & Supplies - Cardiology, Neurology, Vascular Group

PEN : 332.13 (+0.20%)
1 Profitable Stock on Our Buy List and 2 We Brush Off

1 Profitable Stock on Our Buy List and 2 We Brush Off

SHOP : 131.15 (+3.32%)
CWK : 14.63 (+4.28%)
PEN : 332.13 (+0.20%)
Are EHAB, SLAB, PEN, SKYT Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

EHAB : 13.72 (-0.07%)
SKYT : 32.89 (+1.11%)
PEN : 332.13 (+0.20%)
SLAB : 212.89 (+0.29%)
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SLAB, PEN, SKYT, and EHAB

NEW YORK , March 30, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

EHAB : 13.72 (-0.07%)
SKYT : 32.89 (+1.11%)
PEN : 332.13 (+0.20%)
SLAB : 212.89 (+0.29%)
2 Reasons to Avoid PEN and 1 Stock to Buy Instead

2 Reasons to Avoid PEN and 1 Stock to Buy Instead

PEN : 332.13 (+0.20%)
Why Boston Scientific's Big Dip Could Be a Bigger Opportunity

Boston Scientific's pending trial results could help to drive sales growth for years to come after lower-than-expected sales forecasts.

BSX : 64.23 (+1.28%)
PEN : 332.13 (+0.20%)
1 Growth Stock to Stash and 2 We Avoid

1 Growth Stock to Stash and 2 We Avoid

GTLB : 21.42 (-1.88%)
IIIN : 26.22 (-8.03%)
PEN : 332.13 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

3rd Resistance Point 334.01
2nd Resistance Point 333.52
1st Resistance Point 332.83
Last Price 332.13
1st Support Level 331.65
2nd Support Level 331.16
3rd Support Level 330.47

See More

52-Week High 362.41
Last Price 332.13
Fibonacci 61.8% 308.49
Fibonacci 50% 291.83
Fibonacci 38.2% 275.18
52-Week Low 221.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.